Racial Disparities in Early-Stage NSCLC Treatment: A Call for Action.
Bruna PelliniAadel A ChaudhuriPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Non-small cell lung cancer (NSCLC) is associated with a 5-year survival rate of only 28%; however, when caught at an early stage, it can be cured with surgery or stereotactic body radiotherapy (SBRT). Unfortunately, racial disparities may result in limited access to care for some patients. Liu and colleagues analyzed 64,999 cases of early-stage NSCLC treated between 2005 and 2017 from the Florida Cancer Registry and showed that Black patients had 36% lower odds of receiving curative-intent surgery compared with their White counterparts. This study highlights significant racial disparities in treatment patterns that must be addressed urgently. See related article by Liu and colleagues, Cancer Epidemiol Biomarkers Prev 2024;33:489-99.
Keyphrases
- early stage
- end stage renal disease
- small cell lung cancer
- newly diagnosed
- ejection fraction
- prognostic factors
- minimally invasive
- chronic kidney disease
- radiation therapy
- healthcare
- papillary thyroid
- peritoneal dialysis
- coronary artery bypass
- advanced non small cell lung cancer
- squamous cell carcinoma
- sentinel lymph node
- young adults
- acute coronary syndrome
- squamous cell
- chronic pain
- lymph node
- surgical site infection
- tyrosine kinase
- lymph node metastasis
- free survival